(1) - Blood products derived from non-human animals for hemostatic control, namely, compositions containing freeze-dried platelets, cellular components of freeze-dried platelets, rehydrated freeze-dried platelets, or rehydrated cellular components of freeze-dried platelets for intravenous administration to control hemostatic properties in non-human animals
(2) - Research and development in the field of blood productions for non-human animals
(3) - Blood products derived from non-human animals for hemostatic control, namely, compositions containing freeze-dried platelets, cellular components of freeze-dried platelets, rehydrated freeze-dried platelets, or rehydrated cellular components of freeze-dried platelets for intravenous administration to control hemostatic properties in non-human animals
(4) - Blood products derived from non-human animals for hemostatic control, namely, blood substitutes, namely, compositions containing freeze-dried platelets, cellular components of freeze-dried platelets, rehydrated freeze-dried platelets, or rehydrated cellular components of freeze-dried platelets for intravenous administration to control hemostatic properties in non-human animals
(5) - Research and development in the field of blood productions for non-human animals.
(6) - Research and development in the field of blood productions for non-human animals
|